TrendTraderスレ主Howe0308:
It was more likely about 15 min ago than it is now. IF it has broken through 6, 6.05 and 6.15 quickly it is likely it would have continued to move upward
$G1セラピューティクス(GTHX.US)$Watching G1 Therapeutics; Traders Circulate M&A Blog Suggesting Company Rumored To Have A CVR Aspect That Could Value The Company At Between $12-$14/Share
$G1セラピューティクス(GTHX.US)$Really hope this is just a delayed reaction? ( pretty bullish PR ) And not a indication of what the market is going to do again today? Because that terrible JEROME POWELL is going to run his mouth today. Hehehe! I think he is banging JANETYELLEN! Its her sexy hairstyle that has him more focused on her than actually doing anything to fix the economic numbers! Just thinking outloud! Hehehe
$G1セラピューティクス(GTHX.US)$G1 Therapeutics Inc: Eligible to Receive a Maximum of $135M Upon Achievement of Development and Commercial Milestones in up to Three Indications
1
1
報告
Trytosaveabitスレ主 :
G1 Therapeutics Inc: Pepper Bio Will Pay G1 a Double-Digit Royalty on Aggregate Annual Net Sales of Lerociclib
1.$Annovis Bio Inc(ANVS.US)$ • Ph 3 data (also Ph 2/3 in AD). • Buntanetap for Parkinson’s Disease. • Exp Jan '24 but delayed (est this qtr). 2.$アクサム セラピューティクス(AXSM.US)$ • Ph 3 data (SYMPHONY). • AXS-12 for Narcolepsy. • AXS-12 has Orphan Drug Designation. 3.$G1セラピューティクス(GTHX.US)$ • Ph 3 Overall Survival (OS) data. • Trilaciclib (combo) for breast cancer (mTNBC). • DMC recommended continuation earlier in Feb. 4.$クリネティック ファーマシューティカルズ(CRNX.US)$ • Ph 3 data (PATHFND...
Howe0308 : Really?
TrendTraderスレ主 Howe0308: It was more likely about 15 min ago than it is now.
IF it has broken through 6, 6.05 and 6.15 quickly it is likely it would have continued to move upward